Lilly said it doesn't believe patients should be exposed to "the risks in taking untested, unapproved knockoffs." "FDA has rightly and repeatedly expressed concerns with unapproved GLP-1 drugs used for weight loss, and that such drugs are risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed," the company said in a statement to FOX Business
Others describe delays of two to three weeks, particularly during high-demand periods
GLP-1s may also change your palate, causing previously enjoyable dishes to be unappetizing
Unique to retatrutide: dysesthesia Here is where retatrutide diverges from the other two
Greasy, high-fat, heavy foods put me in the bathroom all day and too much sugar made me nauseous
These supplements help fill the gaps